What is the translation of " NEBULISER SOLUTION " in Croatian?

• otopina za atomizator
• otopinom za nebulizator
• otopine za atomizator
• otopinu za nebulizator
• otopinom za atomizator
• otopina za nebulizer

Examples of using Nebuliser solution in English and their translations into Croatian

Vantobra 170 mg nebuliser solution Tobramycin.
Vantobra 170 mg otopina za atomizator Tobramicin.

PHARMACEUTICAL FORM Powder and solvent for nebuliser solution.
FARMACEUTSKI OBLIK Prašak i otapalo za otopinu za atomizator.

After reconstitution the nebuliser solution contains 75 mg aztreonam.
Nakon rekonstitucije otopina za atomizator sadrži 75 mg aztreonama.

Cayston is a white to off-white powder and solvent for nebuliser solution.
Cayston je bijeli do bjelkasti prašak i otapalo za otopinu za atomizator.

Ventavis 10 microgram/ml nebuliser solution 1 ml ampoule.
Ventavis 10 mikrograma/ml otopina za atomizator ampula od 1 ml.

Ventavis 10 microgram/ml(1 ml ampoule) and Ventavis 20 microgram/ml nebuliser solution.
Ventavis 10 mikrograma/ml(ampula od 1 ml) i Ventavis 20 mikrograma/ml otopina za atomizator.

Ventavis 10 microgram/ml nebuliser solution Iloprost.
Ventavis 10 mikrograma/ml otopina za atomizator iloprost.

Ventavis 10 microgram/ml is provided in colourless ampoules, containing either 1 ml or 2 ml nebuliser solution.
Ventavis 10 mikrograma/ml je dostupan u bezbojnim ampulama koje sadrže ili 1 ml ili 2 ml otopine za atomizator.

Ventavis 10 microgram/ml nebuliser solution 2 years.
Ventavis 10 mikrograma/ml otopina za atomizator 2 godine.

See also section 5.1 for the profile of response of TOBI Podhaler compared to tobramycin nebuliser solution.
Vidjeti također dio 5.1 za profil odgovora na TOBI Podhaler u usporedbi s tobramicin otopinom za nebulizator.

Ventavis 20 microgram/ml nebuliser solution 5 years.
Ventavis 20 mikrograma/ml otopina za atomizator 5 godina.

Adult patients tended to discontinue more frequently for tolerability reasons with TOBI Podhaler than with the nebuliser solution.
Odrasli bolesnici bili su skloniji učestalijim prekidima liječenja zbog manje podnošljivosti s TOBI Podhalerom nego s otopinom za nebulizator.

Package contains 56 ampoules with nebuliser solution in 7 pouches.
Pakiranje sadrži 56 ampula s otopinom za atomizator zapakiranih u 7 vrećica.

The ready-to-use Ventavis nebuliser solution is administered with a suitable inhalation device(nebuliser) see below and section 6.6.
Spremna za upotrebu, otopina za atomizator Ventavis primjenjuje se s odgovarajućim uređajem za inhalaciju(atomizatorom) vidjeti niže i dio 6.6.

Both medicines are available as a nebuliser solution.
Oba su lijeka dostupna kao otopina za nebulizer.

Ampoules with 1 ml nebuliser solution for the use of Breelib or I-Neb AAD.
Ampule s 1 ml otopine za atomizator za primjenu pomoću uređaja Breelib ili I-Neb AAD.

Quinsair is a clear, pale yellow nebuliser solution.
Quinsair je bistra, blijedožuta otopina za atomizator.

Vantobra is available as a nebuliser solution in single-dose containers called‘ampoules.
Vantobra je dostupan kao otopina za nebulizer u spremniku za jednu dozu naziva"ampule.

One carton with the medicinal product: 56 ampoules with nebuliser solution in 7 pouches.
Jedna kutija s lijekom: 56 ampula s otopinom za atomizator zapakiranih u 7 vrećica.

Ventavis 10 microgram/ml nebuliser solution Ventavis 20 microgram/ml nebuliser solution.
Ventavis 10 mikrograma/ml otopina za atomizator Ventavis 20 mikrograma/ml otopina za atomizator.

MARKETING AUTHORISATION NUMBER(S) Ventavis 10 microgram/ml nebuliser solution.
BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Ventavis 10 mikrograma/ml otopina za atomizator.

Ventavis 10 microgram/ml nebuliser solution Clear, colourless solution..
Ventavis 10 mikrograma/ml otopina za atomizator Bistra, bezbojna otopina..

The proportions of patients requiring hospitalisation for respiratory events were 24.4% with TOBI Podhaler and 22.0% with TOBI nebuliser solution.
Udjeli bolesnika kojima je bila potrebna hospitalizacija zbog respiratornih događaja bili su 24,4% s TOBI Podhalerom i 22,0% s TOBI otopinom za nebulizator.

Ventavis 20 microgram/ml nebuliser solution Clear, colourless to slightly yellowish solution..
Ventavis 20 mikrograma/ml otopina za atomizator Bistra, bezbojna do blago žućkasta otopina..

To obtain the optimal droplet size for the administration of Ventavis 10 microgram/ml nebuliser solution the green baffle plate should be used.
Da bi se postigla optimalna veličina kapljica za primjenu Ventavis 10 mikrograma/ml otopine za atomizator, potrebno je koristiti zelenu ploču.

Ventavis 10 microgram/ml nebuliser solution is inhaled using the nebulisers your doctor prescribed either the Breelib, the Venta-Neb or the I-Neb AAD system.
Ventavis 10 mikrograma/ml otopina za atomizator inhalira se pomoću atomizatora kojeg Vam je propisao liječnik sustav Breelib, Venta-Neb ili I-Neb AAD.

The extent of systemic exposure(AUC) was also similar for the 112 mg TOBI Podhaler dose and the 300 mg tobramycin nebuliser solution dose.
Razmjer sistemske izloženosti(AUC) bio je također sličan za dozu od 112 mg TOBI Podhalera i za dozu od 300 mg tobramicin otopine za nebulizator.

Ventavis 10 microgram/ml nebuliser solution(1 ml ampoule) delivers 2.5 microgram and Ventavis 20 microgram/ml nebuliser solution delivers 5 microgram at the mouthpiece of the Breelib nebuliser..
Ventavis 10 mikrograma/ml(ampula od 1 ml) otopina za atomizator isporučuje 2, 5 mikrograma, a Ventavis 20 mikrograma/ml otopina za atomizator isporučuje 5 mikrograma u nastavku za usta Breelib atomizatora..

The I-Neb AAD nebuliser has been shown to be suitable for the administration of Ventavis 10 microgram/ml(1 ml ampoule) and 20 microgram/ml nebuliser solution.
Atomizator I-Neb AAD pokazao se prikladnim za primjenu Ventavis 10 mikrograma/ml(ampula od 1 ml) i 20 mikrograma/ml otopine za atomizator.

Treatment with both TOBI Podhaler and tobramycin 300 mg/5 ml nebuliser solution(TOBI) resulted in relative increases from baseline to day 28 of the third treatment cycle in percent predicted FEV1 of 5.8% and 4.7%, respectively.
Liječenje TOBI Podhalerom i tobramicin 300 mg/5 ml otopinom za nebulizator(TOBI) rezultiralo je relativnim povećanjem od početne vrijednosti do 28. dana trećeg ciklusa terapije u postotku predviđenog FEV1 od 5,8% odnosno 4, 7.